정형외과용 지관절 임플란트 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 재료별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Orthopedic Digit Implants Market Summary

The global orthopedic digit implants market size was estimated at USD 283.44 million in 2024 and is projected to reach USD 488.89 million by 2033, growing at a CAGR of 6.17% from 2025 to 2033. The rising prevalence of orthopedic conditions such as rheumatoid arthritis and osteoarthritis is expected to drive market growth.

This trend, coupled with an aging population and increasing demand for joint preservation solutions, is fueling the adoption of advanced orthopedic implants. In February 2025, SingleCare reported that nearly 1 in 4 American adults has arthritis, with osteoarthritis being the most common form. The article highlights that more than 33 million U.S. adults are affected by osteoarthritis, and the economic burden exceeds USD 300 billion annually. Arthritis is also a leading cause of work limitations in the U.S., with 25.7 million adults experiencing physical restrictions. Increasing technological advancements in orthopedic implants including orthopedic digit implants is anticipated to accelerate market growth. Advanced biomaterials with better biocompatibility and durability have improved the quality of implants, leading to an increase in their demand. These biomaterials consist of ceramics and alloys that imitate the properties of natural bone and joints, which has further contributed to market growth. The use of computer-aided design and biomechanics studies has also played a significant role in the development of precise implant designs, further boosting the market growth. In March 2024, OrthoVentions LLC made an investment in MotioOV, which is an early-stage company that was created in partnership with the Hospital for Special Surgery (HSS). MotioOV's focus is to develop a unique 3D printed implant as well as custom instruments that can help address issues related to stiffness and pain caused by arthritis of the first metatarsophalangeal (MTP) joint.

Increasing demand for minimally invasive procedures drives the demand for orthopedic digit implants. The increasing adoption of organic and inorganic strategies by the key market players is expected to spur market growth. For instance, in January 2024, Extremity Medical LLC, a medical engineering firm, has announced a strategic relationship with Henry Schein, Inc., a global healthcare solutions company. This partnership will help Extremity Medical expand its innovative orthopedic extremity implant systems. In addition, the company completed growth debt financing from June through November, which will help fuel its growth. Such initiatives undertaken by market players will foster market growth.

The orthopedic industry is expected to experience rapid growth due to the increasing number of new players entering the market. In April 2024, Henry Schein, Inc., the largest provider of healthcare solutions for dental and medical practitioners, announced the completion of its acquisition of TriMed, Inc. TriMed is a global developer of orthopedic solutions for the treatment of upper extremities like hands and wrists, and lower extremities like feet and ankles. Henry Schein had announced its intention to acquire a majority interest in TriMed on December 20, 2023. With this acquisition, Henry Schein entered the market for orthopedic extremities.

Increasing government and non-government initiatives escalate the market growth. For instance, in June 2022, Loci Orthopaedics, a Medtech start-up, received USD 8 million in funding and financial support from the European Commission's European Innovation Council (EIC) Accelerator Programme. The grant and equity investment will be utilized to conduct a clinical trial of the company's implant treatment for thumb arthritis, before proceeding to full-scale commercialization.

Global Orthopedic Digit Implants Market Report Segmentation

This report forecasts revenue and volume growth at global, regional, and country level and provides an analysis on industry trends in each of the sub segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global orthopedic digit implants market report based on product, material, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Metatarsal joint implants
• Metacarpal joint implants
• Hemi phalangeal implants
• Scaphoid bone implants
• Toe intramedullary implants
• Material Outlook (Revenue, USD Million, 2021 - 2033)
• Titanium
• Nitinol
• Silicon pyrocarbon
• Stainless steel
• Other materials
• End Use Outlook (Revenue USD Million, 2021 - 2033)
• Hospitals
• Outpatient Facilities
• Regional Outlook Revenue USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Spain
  • Italy
  • France
  • Denmark
  • Norway
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Material outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Orthopedic Digit Implants Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing number of sports injuries and road traffic accidents
    • 3.2.1.2. Growing population aged 25 to 65 years and increasing burden of global geriatric population
    • 3.2.1.3. Increasing adoption of minimally invasive treatments
    • 3.2.1.4. Increasing reimbursement coverage
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Stringent regulatory framework
    • 3.2.2.2. Increasing number of product recalls
• 3.3. Orthopedic digit implants: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Orthopedic Disease Prevalence
• 3.5. Initiatives by key stakeholders in the Orthopedic Industry
• 3.6. Orthopedic Technology Trends for 2024
• 3.7. Regulatory Landscape and Compliance
• 3.8. Investment activity and M&A trends within orthopedics sectors
• 3.9. Emerging Business Models in the Orthopedic Sector
• 3.10. Supply Chain Management in the Orthopedic Digit Implants Market

Chapter 4. Orthopedic Digit Implants Market Segment Analysis, By Product, 2021 - 2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Product Market Share Analysis, 2024 & 2033
• 4.3. Segment Dashboard
• 4.4. Global orthopedic digit implants market, by product, 2021 to 2033
• 4.5. Metatarsal joint implants
  • 4.5.1. Metatarsal joint implants market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.6. Metacarpal joint implants
  • 4.6.1. Metacarpal joint implants market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.7. Hemi phalangeal implants
  • 4.7.1. Hemi phalangeal implants market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.8. Scaphoid bone implants
  • 4.8.1. Scaphoid bone implants market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.9. Toe intramedullary implants
  • 4.9.1. Toe intramedullary implants market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Orthopedic Digit Implants Market Segment Analysis, By Material, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. Material Market Share Analysis, 2024 & 2033
• 5.3. Segment Dashboard
• 5.4. Global orthopedic digit implants market, by material, 2021 to 2033
• 5.5. Titanium
  • 5.5.1. Titanium market estimates and forecasts, 2021 to 2033 (USD million)
• 5.6. Nitinol
  • 5.6.1. Nitinol market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.7. Silicone
  • 5.7.1. Silicone market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.8. Stainless steel
  • 5.8.1. Stainless steel market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.9. Other materials
  • 5.9.1. Other materials market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Orthopedic Digit Implants Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

• 6.1. Definition and Scope
• 6.2. End Use Market Share Analysis, 2024 & 2033
• 6.3. Segment Dashboard
• 6.4. Global orthopedic digit implants Market, by end-use, 2021 to 2033
• 6.5. Hospitals
  • 6.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD million)
• 6.6. Outpatient facilities
  • 6.6.1. Outpatient facilities market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Orthopedic Digit Implants Market Segment Analysis, By Region, By Product, By Material, By End Use, 2021- 2033 (USD Million)

• 7.1. Regional Market Share Analysis, 2024 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Regional Market Snapshot
• 7.4. Orthopedic Digit Implants Market Share by Region, 2024 & 2033:
• 7.5. North America
  • 7.5.1. North America orthopedic digit implants market, 2021 - 2033 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. U.S. orthopedic digit implants market, 2021 - 2033 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Canada orthopedic digit implants market, 2021 - 2033 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Mexico orthopedic digit implants market, 2021 - 2033 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe orthopedic digit implants market, 2021 - 2033 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. UK orthopedic digit implants market, 2021 - 2033 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Germany orthopedic digit implants market, 2021 - 2033 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. France orthopedic digit implants market, 2021 - 2033 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Italy orthopedic digit implants market, 2021 - 2033 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework
    • 7.6.6.3. Competitive Scenario
    • 7.6.6.4. Spain orthopedic digit implants market, 2021 - 2033 (USD Million)
  • 7.6.7. Norway
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Framework
    • 7.6.7.3. Competitive Scenario
    • 7.6.7.4. Norway orthopedic digit implants market, 2021 - 2033 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Regulatory Framework
    • 7.6.8.3. Competitive Scenario
    • 7.6.8.4. Sweden orthopedic digit implants market, 2021 - 2033 (USD Million)
  • 7.6.9. Denmark
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Regulatory Framework
    • 7.6.9.3. Competitive Scenario
    • 7.6.9.4. Denmark orthopedic digit implants market, 2021 - 2033 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key Country Dynamics
    • 7.7.1.2. Regulatory Framework
    • 7.7.1.3. Competitive Scenario
    • 7.7.1.4. Japan orthopedic digit implants market, 2021 - 2033 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. China orthopedic digit implants market, 2021 - 2033 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Framework
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. India orthopedic digit implants market, 2021 - 2033 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Regulatory Framework
    • 7.7.4.3. Competitive Scenario
    • 7.7.4.4. Australia orthopedic digit implants market, 2021 - 2033 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Regulatory Framework
    • 7.7.5.3. Competitive Scenario
    • 7.7.5.4. South Korea orthopedic digit implants market, 2021 - 2033 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Regulatory Framework
    • 7.7.6.3. Competitive Scenario
    • 7.7.6.4. Thailand orthopedic digit implants market, 2021 - 2033 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key Country Dynamics
    • 7.8.1.2. Regulatory Framework
    • 7.8.1.3. Competitive Scenario
    • 7.8.1.4. Brazil orthopedic digit implants market, 2021 - 2033 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework
    • 7.8.2.3. Competitive Scenario
    • 7.8.2.4. Argentina orthopedic digit implants market, 2021 - 2033 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key Country Dynamics
    • 7.9.1.2. Regulatory Framework
    • 7.9.1.3. Competitive Scenario
    • 7.9.1.4. South Africa orthopedic digit implants market, 2021 - 2033 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Regulatory Framework
    • 7.9.2.3. Competitive Scenario
    • 7.9.2.4. Saudi Arabia orthopedic digit implants market, 2021 - 2033 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Regulatory Framework
    • 7.9.3.3. Competitive Scenario
    • 7.9.3.4. UAE orthopedic digit implants market, 2021 - 2033 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Regulatory Framework
    • 7.9.4.3. Competitive Scenario
    • 7.9.4.4. Kuwait orthopedic digit implants market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Profiles
  • 8.3.1. Stryker
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Product benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. Zimmer Biomet
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Smith+Nephew
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. DePuy Synthes
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Arthrex Inc
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Acumed LLC
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Anika Therapeutics, Inc.
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. VILEX, LLC
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Paragon 28
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Extremity Medical LLC
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives